Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature

doi:10.12998/wjcc.v9.i4.919

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5620)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

339

WORD

164

HTML

2872

Figures (1-4)

421

Tables (1-1)

447

Sum=4243

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

392

Download

985

Sum=1377

Feb 6, 2021 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 6, 2021; 9(4): 919-926
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.919

Full Size Figure Download Figure

Figure 2 Magnetic resonance imaging finding. No abnormal lesions were found in either breast.

Citation: Zhang Y, Wu D, Zhao B, Tian XL, Yao TC, Li F, Liu WF, Shi AP. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature. World J Clin Cases 2021; 9(4): 919-926
URL: https://www.wjgnet.com/2307-8960/full/v9/i4/919.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i4.919